Literature DB >> 21422237

Dapsone-associated methemoglobinemia in a patient with slow NAT2*5B haplotype and impaired cytochrome b5 reductase activity.

Mahmoud Abouraya1, James C Sacco, Kristie Hayes, Sajeve Thomas, Craig S Kitchens, Lauren A Trepanier.   

Abstract

Entities:  

Keywords:  Methemoglobin; N-acetylation; adverse drug reaction; arylamine

Mesh：

Substances：

Year:  2012        PMID： 21422237      PMCID： PMC3153586          DOI： 10.1177/0091270010393343

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  44 in total

1.  Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicity.

Authors:  T Simon; L Becquemont; M Mary-Krause; I de Waziers; P Beaune; C Funck-Brentano; P Jaillon
Journal:  Clin Pharmacol Ther       Date:  2000-04       Impact factor: 6.875

2.  CYP2C8/9 mediate dapsone N-hydroxylation at clinical concentrations of dapsone.

Authors:  H R Winter; Y Wang; J D Unadkat
Journal:  Drug Metab Dispos       Date:  2000-08       Impact factor: 3.922

Review 3.  Methemoglobinemia: etiology, pharmacology, and clinical management.

Authors:  R O Wright; W J Lewander; A D Woolf
Journal:  Ann Emerg Med       Date:  1999-11       Impact factor: 5.721

4.  N-Acetyltransferase2 genotype correlated with isoniazid acetylation in Japanese tuberculous patients.

Authors:  T Kita; Y Tanigawara; S Chikazawa; H Hatanaka; T Sakaeda; F Komada; S Iwakawa; K Okumura
Journal:  Biol Pharm Bull       Date:  2001-05       Impact factor: 2.233

5.  Functional characterization of human N-acetyltransferase 2 (NAT2) single nucleotide polymorphisms.

Authors:  A J Fretland; M A Leff; M A Doll; D W Hein
Journal:  Pharmacogenetics       Date:  2001-04

6.  Dapsone-induced methemoglobinemia in pediatric oncology patients: case examples.

Authors:  B N Mandrell; J N McCormick
Journal:  J Pediatr Oncol Nurs       Date:  2001 Sep-Oct       Impact factor: 1.636

Review 7.  Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients.

Authors:  Martin Rodriguez; Jay A Fishman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus.

Authors:  Ichiro Watanabe; Aiko Tomita; Miho Shimizu; Mie Sugawara; Hiroaki Yasumo; Ryuta Koishi; Tohru Takahashi; Kaoru Miyoshi; Kouichi Nakamura; Takashi Izumi; Yasuyuki Matsushita; Hidehiko Furukawa; Hideyuki Haruyama; Teiichiro Koga
Journal:  Clin Pharmacol Ther       Date:  2003-05       Impact factor: 6.875

9.  Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals.

Authors:  Rachel Ash-Bernal; Robert Wise; Scott M Wright
Journal:  Medicine (Baltimore)       Date:  2004-09       Impact factor: 1.889

10.  The haemolytic effects of diaphenylsulfone (DDS) in normal subjects and in those with glucose-6-phosphate-dehydrogenase deficiency.

Authors:  R L Degowin; R B Eppes; R D Powell; P E Carson
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408
View more
  2 in total

1.  Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection.

Authors:  Yat Yee Wong; Eva G Rakasz; David J Gasper; Thomas C Friedrich; Lauren A Trepanier
Journal:  Toxicology       Date:  2016-08-23       Impact factor: 4.221

2.  Case Study 10: A Case to Investigate Acetyl Transferase Kinetics.

Authors:  Jennifer L Dumouchel; Valerie M Kramlinger
Journal:  Methods Mol Biol       Date:  2021
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.